Prophylaxis of hemicrania continua: Two new cases effectively treated with topiramate

Headache

Volumn 47, Issue 3, 2007, Pages 441-443

  Brighina, Filippo ^a   Palermo, Antonio ^a   Cosentino, Giuseppe ^a   Fierro, Brigida ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Hemicrania continua; Prophylaxis; Topiramate

Indexed keywords

INDOMETACIN; TOPIRAMATE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; GASTRITIS; HEMICRANIA CONTINUA; HUMAN; LACRIMATION; MIGRAINE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; FEMALE; FRUCTOSE; GASTRITIS; HEADACHE; HUMANS; INDOMETHACIN; MIDDLE AGED; RETREATMENT;

EID: 33947207384     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00733.x     Document Type: Article

References (15)

1. Medina JL, Diamond S. Cluster headache variant. Spectrum of a new headache syndrome. Arch Neurol. 1981;38:705-709.
2. Sjaastad O, Spierings EL. Hemicrania continua: Another headache absolutely responsive to indomethacin. Cephalalgia. 1984;4:65-70.
3. Headache Classification Committee of The International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia. 2004;24:1-195.
4. Newman LC, Lipton RB, Russell M, Solomon S. Hemicrania continua: Attacks may alternate sides. Headache. 1992;32:237-238.
5. Matharu MS, Boes CJ, Goadsby PJ. Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs. 2003;63:1637-1677.
6. Matharu MS, Cohen AS, McGonigle DJ, Ward N, Frackowiak RS, Goadsby PJ. Posterior hypothalamic and brainstem activation in hemicrania continua. Headache. 2004;44:747-761.
7. Newman LC, Lipton RB, Solomon S. Hemicrania continua: Ten new cases and a review of the literature. Neurology. 1994;44:2111-2114.
8. Matharu MS, Bradbury P, Swash M. Hemicrania continua: Side alternation and response to topiramate. Cephalalgia. 2005;26:341-344.
9. Lenzer J. FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke. BMJ. 2005;330:440.
10. Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol. 2004;61:490-495.
11. Shuaib A. Efficacy of topiramate in prophylaxis of frequent severe migraines or chronic daily headaches: Experience with 68 patients over 18 months. Cephalalgia. 2000;20:423.
12. Haugh MJ, Connor GS. Favourable response of trigeminal neuralgia to the anticonvulsant topiramate: A retrospective study. Cephalalgia. 2000;20:379.
13. Wheeler SD, Carrazana EJ. Topiramate-treated cluster headache. Neurology. 1999;53: 234-236.
14. Matharu MS, Boes CJ, Goadsby PJ. SUNCT syndrome. Prolonged attacks, refractoriness and response to topiramate. Neurology. 2002;58:1307.
15. Rosenfeld WE. Topiramate: A review of the preclinical, pharmacokinetic, and clinical data. Clin Ther. 1997;19:1294-1308.